Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)
(PAR-21-313)
National Institute of Diabetes and Digestive and Kidney Diseases
National Human Genome Research Institute
Application Receipt Date(s): September 07, 2024
Time-Sensitive Obesity Policy and Program Evaluation (R01 Clinical Trial Not Allowed)
(PAR-21-305)
National Institute of Diabetes and Digestive and Kidney Diseases
National Cancer Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Office of Disease Prevention
Application Receipt Date(s): September 22, 2021 (first deadline)
Selectively Target Technology Development to Understand How Changes or Dysfunction at the Capillary, Arterioles, and Small Lymphatic Vessels Level Can Have Long-term Impact on AD/ADRD (R01 Clinical Trial Not Allowed)
(PAR-22-026)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
Application Receipt Date(s): November 8, 2021
Autism Centers of Excellence: Networks (R01 Clinical Trial Optional)
(RFA-HD-22-007)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Deafness and Other Communication Disorders
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): November 9, 2021
Autism Centers of Excellence: Centers (P50 Clinical Trial Optional)
(RFA-HD-22-008)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Deafness and Other Communication Disorders
National Institute of Environmental Health Sciences
National Institute of Mental Health
National Institute of Neurological Disorders and Stroke
Application Receipt Date(s): November 9, 2021
Clinical and Biological Measures of TBI-related Dementia Including Chronic Traumatic Encephalopathy (R01 Clinical Trial Not Allowed)
(PAR-22-024)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
Application Receipt Date(s): November 10, 2021
Feasibility Studies that Explore Healthy and Diseased Temporomandibular Joints (TMJ) using Single Cell Multi-Omic Analyses (UH2/UH3 Clinical Trial Not Allowed)
(RFA-DE-22-005)
National Institute of Dental and Craniofacial Research
Office of Research on Women’s Health
Application Receipt Date(s): November 10, 2021
Innovative Approaches for Improving Environmental Health Literacy (R43/R44 Clinical Trial Not Allowed)
(RFA-ES-21-008)
National Institute of Environmental Health Sciences
Application Receipt Date(s): November 10, 2021
Innovative Approaches for Improving Environmental Health Literacy (R41/R42 Clinical Trial Not Allowed)
(RFA-ES-21-009)
National Institute of Environmental Health Sciences
Application Receipt Date(s): November 10, 2021
Detecting Cognitive Impairment, Including Dementia, in Primary Care and Other Everyday Clinical Settings for the General Public and Health Equity, Pragmatic Clinical Trials (U01 Clinical Trial Required)
(RFA-NS-22-009)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
Application Receipt Date(s): November 10, 2021
Fentanyl and its Analogs: Effects and Consequences for Treatment of Addiction and Overdose (UG3/UH3 Clinical Trial Optional)
(RFA-DA-22-022)
National Institute on Drug Abuse
Application Receipt Date(s): November 11, 2021
Small Vessel VCID Biomarkers Validation Consortium Coordinating Center (U24 Clinical Trial Not Allowed)
(RFA-NS-22-017)
National Institute of Neurological Disorders and Stroke
National Institute on Aging
Application Receipt Date(s): November 12, 2021
Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 – Clinical Trial Not Allowed)
(PAR-21-277)
National Institute of General Medical Sciences
National Center for Complementary and Integrative Health
National Heart, Lung, and Blood Institute
National Institute of Allergy and Infectious Diseases
National Institute of Dental and Craniofacial Research
National Institute of Mental Health
National Library of Medicine
Office of Research on Women’s Health
Application Receipt Date(s): November 18, 2021 November 15, 2022 November 15, 2023
Impact of Technology and Digital Media (TDM) Exposure/Usage on Child and Adolescent Development (P01 Clinical Trial Optional)
(RFA-HD-22-009)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
Application Receipt Date(s): November 29, 2021
Innovative Multi-Level Approaches and Strategies to Prevent, Test and Treat HIV in Primary Care Settings in Health Disparity Populations in Geographic Hot Spots in the United States (R01 – Clinical Trial Required)
(RFA-MD-22-001)
National Institute on Minority Health and Health Disparities
National Institute of Mental Health
Application Receipt Date(s): January 14, 2022
American Women: Assessing Risk Epidemiologically (AWARE) (R01 Clinical Trial Optional)
(RFA-AI-21-058)
National Institute of Allergy and Infectious Diseases
National Institute on Alcohol Abuse and Alcoholism
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute on Drug Abuse
National Institute of Mental Health
Office of Behavioral and Social Sciences Research
Office of Research on Women’s Health
Application Receipt Date(s): See announcement
Dementia Care and Caregiver Support Intervention Research (R01 Clinical Trial Required)
(PAR-21-307)
National Institute on Aging
Application Receipt Date(s): Multiple dates, see announcement.
Pragmatic Trials for Dementia Care and Caregiver Support (R61/R33 Clinical Trial Required)
(PAR-21-308)
National Institute on Aging
Application Receipt Date(s): Multiple dates, see announcement.
Multipurpose Prevention Technology: Novel Systemic Options for Young Adults (R43/R44 Clinical Trial Not Allowed)
(PAR-21-297)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Allergy and Infectious Diseases
National Institute of Mental Health
Application Receipt Date(s): See announcement
Multipurpose Prevention Technology: Novel Systemic Options for Young Adults (R41/R42 Clinical Trial Not Allowed)
(PAR-21-298)
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
Application Receipt Date(s): See announcement